Articles

How much is an ABA practice worth?

Adjusted EBITDA times a multiple gives the enterprise value; the debt, fees, the recoupment escrow and the rollover decide what the owner actually receives.

An ABA practice is worth its adjusted EBITDA times a multiple, less the debt repaid at closing, with fees, a recoupment escrow and any rollover taken from the equity. In the book's fictional case a platform offered 6.0 times $557,855, an enterprise value of $3,347,130, which left the owner $1,061,372 of cash at closing.

Worked in full in The ABA Therapy Practice Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback

Free: the ABA Practice Utilization, Revenue per Client and Break-Even Calculator, an Excel workbook that returns net revenue and contribution per client a month, the margin on direct costs per billed hour, the break-even in active clients before and after debt service, and what five more points of utilization are worth.

SDE or adjusted EBITDA: which earnings a buyer prices

An ABA practice is worth its earnings times a multiple, and the first question is which earnings. Seller's discretionary earnings (SDE) are EBITDA plus the owner's salary and its burden: earnings before any pay to the owner. A BCBA who will buy the practice and run it herself reads SDE. Adjusted EBITDA is SDE less the cost of a salaried clinical director to do the owner's work. A buyer that must pay someone to run the practice reads that.

In the book's fictional case, Tamberwick Autism Therapy, that cost is set at $152,753 a year (a salary of $135,000 plus burden of 13.15 percent, a case assumption). SDE was $430,197 in FY2025 and $667,322 in FY2026; adjusted EBITDA $277,444 and $514,569. How platforms buy practices, and at what multiples, is not covered in this article; the case's letter is one fictional letter, and its multiple is the buyer's figure.

The trap: an SDE figure multiplied by an EBITDA multiple. The owner's pay is then both added back and still owed to whoever does her work. In the case, applying the letter's 6.0 times to SDE of $667,322 would give $4,003,932, $656,802 more than the letter: $916,518 for the clinical director's cost a buyer must pay after closing, less $259,716 for a one-time add-back the letter counts and SDE does not.

Example 1: from SDE to enterprise value

On 21 October 2026 a platform of ABA practices backed by a private equity fund (neither named) sent the owner a letter of intent. Its arithmetic:

The buyer's adjusted EBITDA (Tamberwick, fictional; the buyer's figures).
LineAmount
FY2026 EBITDA$531,542
Add back: the owner's salary and burden$135,780
SDE$667,322
Less: cost of a clinical director to do the owner's work−$152,753
Add back: second center pre-opening costs, treated as one-time$43,286
Adjusted EBITDA$557,855

Enterprise value = $557,855 × 6.0 = $3,347,130, which is 5.02 times SDE (a ratio the buyer does not use)

In the letter, the platform's operating company would buy the assets and employ the BCBAs and RBTs, as counsel structures it. Who may own a practice and who must be licensed varies by state; counsel in the practice's state decides. The letter also leaves to the purchase agreement whether each payer contract and enrollment can pass to the operating company, or whether it must enroll and credential under its own number. The owner's own purchase in 2024, which cost $72,129 of sessions that could not be billed while the payers credentialed her PLLC, shows what that step can cost.

The book goes further: seven Excel workbooks (hours and revenue per client, staff cost, supervision and margin per billed hour, utilization and break-even, RBT turnover, second center budget and payback, purchase and SBA loan, offer to cash), each with an exercise and its answer. See The ABA Therapy Practice Owner · PDF, $19.99

What moves the value of an ABA practice

A buyer reads more than one line of earnings. In the case Medicaid plans paid 51.1 percent of FY2026 net revenue, commercial plans and families 47.1 percent and the school contract 2.3 percent: the revenue by payer a buyer tests for quality of revenue (not the payer mix of the workbooks, a share of active clients). The owner bills no hours, but she holds the payer relationships and the referral sources and signs every treatment plan as clinical director, which is why the letter comes with an employment agreement for her. RBT turnover was 45 percent in FY2026. The second center opened six months before the letter, which offers an earn-out of up to $300,000 if it reaches a FY2027 contribution the letter sets: contingent, and not part of the cash at closing (the article on how an earnout payment is calculated covers the mechanics).

Documentation weighs too. An HHS-OIG audit (December 2024) of one state's Medicaid ABA payments found improper or potentially improper lines in every sampled enrollee-month and recommended postpayment reviews. In the case a Medicaid plan's post-payment review recouped $11,800 in May 2026 for FY2025 sessions, paid from a provision of 1 percent of Medicaid net revenue that the practice books every month.

The recoupment escrow

A person who received a Medicare or Medicaid overpayment reports and returns it within 60 days after identifying it (42 U.S.C. 1320a-7k(d)); a commercial plan's recoupment follows its contract. A buyer therefore asks who bears recoupments on sessions billed before closing. The letter holds 5 percent of enterprise value, $167,357, for 24 months, released later only if no claim takes it. In the 2024 purchase the same question cost the seller $21,400 of a $60,000 escrow.

From enterprise value to the owner's cash

Enterprise value is not what the owner receives. The letter is cash-free and debt-free: the loans are repaid from the price, fees come off, the escrow is held back and part of the equity is rolled into the buyer.

From the headline price to cash at closing (Tamberwick, fictional; balances at 30 September 2026, before taxes).
LineAmount
Enterprise value$3,347,130
SBA loan for the purchase repaid−$1,309,672
SBA loan for the second center repaid−$234,289
Seller note with accrued interest repaid−$91,740
Equity value$1,711,429
Transaction fees (3 percent of enterprise value + $40,000 legal)−$140,414
Recoupment escrow, 5 percent of enterprise value−$167,357
Rollover, 20 percent of equity value, into the platform's holding company−$342,286
Cash to the owner at closing$1,061,372

Outside the price, the PLLC keeps its own cash ($108,671), collects its receivables ($479,267) and keeps its provision for recoupments ($16,270). The rollover is equity in the platform's holding company, not cash, and is worth what that company is worth when it is sold; the article on how rollover equity is calculated covers the mechanics. Once the bank's loans are repaid, the owner's personal guarantees end with them.

After the sale the owner would work for the operating company as clinical director at $135,000 a year ($152,753 with burden): exactly the cost already deducted from SDE. Her future pay is a cost of the buyer, counted once, neither part of the price nor taken twice. Any non-compete in the purchase or employment agreement is a matter of state law; the FTC's Non-Compete Clause Rule was removed on 12 February 2026.

Example 2: the same practice at 5.5 times

Half a turn of multiple moves the owner's cash far more than the price, because the debt does not shrink with it:

The letter at two multiples (Tamberwick, fictional).
Line6.0 times5.5 times
Enterprise value$3,347,130$3,068,203
Debt repaid$1,635,701$1,635,701
Fees$140,414$132,046
Recoupment escrow$167,357$153,410
Rollover$342,286$286,500
Cash at closing$1,061,372$860,546

The price fell by 8.3 percent and the cash at closing by 18.9 percent.

If the buyer is a BCBA with an SBA loan

An individual buyer financing with a 7(a) loan would face the SBA's SOP 50 10 8.1, effective 1 October 2026: an equity injection of at least 10 percent of total project cost that cannot be reduced, a seller note on full standby for no more than half of it, and debt service coverage of 1.25 to 1. On the letter's price alone, 10 percent is $334,713 and half of that $167,357, before working capital and closing costs. That buyer would also price SDE, not adjusted EBITDA, and the lender's coverage test would decide how much of it the loan could carry.

Sources

  1. SBA SOP 50 10 8.1, effective 1 October 2026 (change of ownership, equity injection, maturities)
  2. 42 U.S.C. 1320a-7k(d), reporting and returning Medicare and Medicaid overpayments (United States Code, 2024 edition)
  3. HHS-OIG, audit report A-09-22-02002, December 2024 (ABA codes billed in 15-minute units; one state's Medicaid ABA payments)
  4. Federal Register, 12 February 2026, 91 FR 6507 (Non-Compete Clause Rule removed)

Rules checked on 18 November 2026, federal rules and the certifier's handbooks only, and not legal, tax, accounting or clinical advice. Tamberwick Autism Therapy, its bank, its landlord and the platform that writes to it are fictional: every case figure is a teaching assumption, not a norm. State law is for counsel in the practice's state.

Questions readers ask

What multiple does an ABA practice sell for?

No multiple from the market is given here, because none was verified from a primary source; a buyer sets it from size, growth, the payer mix, the owner's role, turnover and documentation. In the book's fictional letter of intent a platform backed by a private equity fund offered 6.0 times adjusted EBITDA.

Is an ABA practice valued on SDE or EBITDA?

A BCBA who will run the practice herself reads SDE, which adds back the owner's pay. A platform reads adjusted EBITDA, SDE less the cost of a clinical director. In the case SDE was $667,322 and the buyer's adjusted EBITDA $557,855.

Why is the cash at closing so much lower than the price?

Because the loans are repaid from the price, fees are paid, an escrow is held back for payer recoupments and part of the equity is rolled into the buyer. In the case an enterprise value of $3,347,130 left $1,061,372 of cash at closing, plus a rollover of $342,286.

What is a recoupment escrow in the sale of an ABA practice?

Part of the price held back after closing against payer recoupments on sessions billed before it. In the case's letter it is 5 percent of enterprise value, $167,357, held 24 months; in the 2024 purchase, $60,000 held 12 months, of which $21,400 paid a Medicaid plan's recoupment.

Read the whole book

This article is one chapter's worth of arithmetic from The ABA Therapy Practice Owner, which follows one fictional two-center autism therapy practice for 24 months: the purchase with an SBA 7(a) loan and the credentialing transition, Medicaid plans, commercial plans and families, authorizations and the five levels of hours, units and rates, utilization and cancellations, RBT and BCBA cost and supervision, turnover, recoupments, break-even, a second center and a platform's letter of intent taken apart to the owner's cash.

Also on this site